Allergan To Acquire Acelity-Owned LifeCell For $2.9B
Global pharmaceutical giant Allergan PLC said Tuesday it will acquire LifeCell, a New Jersey-based regenerative medicine company owned by Acelity LP, for $2.9 billion in cash, creating a "world-class aesthetic and regenerative...To view the full article, register now.
Already a subscriber? Click here to view full article